Evidence map›Paper›PMID 25749227›Full record

ArticleThe Lancet. Infectious diseases2015

Combined antiparasitic treatment for neurocysticercosis - Authors' reply.

Hector H Garcia, Isidro Gonzales, Javier A Bustos, Herbert Saavedra, Martin Gavidia, Lourdes Rodriguez, Enrique Najar, Hugo Umeres, E Javier Pretell

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Natural History of Treated Subarachnoid Neurocysticercosis.The American journal of tropical medicine and hygiene · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Hector H GarciaCysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Barrios Altos, Lima 1, Peru; Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Perú; Center for Global Health - Tumbes, Universidad Peruana Cayetano Heredia, Lima, Perú. Electronic address: hgarcia@jhsph.edu.
Isidro GonzalesCysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Barrios Altos, Lima 1, Peru.
Javier A BustosDepartment of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Perú
Herbert SaavedraCysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Barrios Altos, Lima 1, Peru.
Martin GavidiaHospital Nacional Edgardo Rebagliatti, ESSALUD, Lima, Perú
Lourdes RodriguezHospital Nacional Guillermo Almenara, ESSALUD, Lima, Perú
Enrique NajarHospital Nacional Cayetano Heredia, Ministerio de Salud, Lima, Perú
Hugo UmeresHospital Nacional Cayetano Heredia, Ministerio de Salud, Lima, Perú
E Javier PretellHospital Nacional Alberto Sabogal, ESSALUD, Callao, Perú

Funding

Neurocysticercosis: Combined Treatment with Praziquantel and AlbendazoleR01NS054805 · NINDS · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO · 2006 to 2012
$2.7M
NINDS NIH HHS R01 NS054805Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlbendazoleAnthelminticsFemaleHumansMaleNeurocysticercosisPraziquantelAlbendazoleAnthelminticsPraziquantel

Identifiers

PMID25749227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.